Danaher Corporation
- DHR
- NYSE
- Medical - Diagnostics & Research
- Life Sciences Tools
- Diagnostics
- Environmental/Water Solutions
$224.43
Today −2.01%Quote Oct 19, 2026, 08:02 PM UTC
+5.96%over the last month
Max drawdown −6.8%From 1-month high −3.1%3 months +25.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Danaher
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Where the money comes from
Q2 2026 revenue $6.26B
- Revenue from Contract with Customer, Measurement, Recurring$5.20B83.0%
- Revenue from Contract with Customer, Measurement, Nonrecurring$1.06B17.0%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Employees
59,000
Dividend date
Oct 30, 2026
Market value
$157.77B
Quote Oct 19
Floor
$220.04
2.0% below price
Resistance
$225.43
0.4% above price
Price vs analyst targets
43 analysts
Lowest target
$195.00Highest target
$250.00
$195.00Highest target
$250.00
- Price $224.43
- Average target $231.82
- Analysts' target range
Analysts' average target sits about 3% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DHRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free